Related Experiment Videos
Aib-based peptide backbone as scaffolds for helical peptide mimics
Raja Banerjee1, Gautam Basu, Patrick Chène
1Department of Biophysics, Bose Institute, Calcutta, India.
Summary
Incorporating alpha-amino isobutyric acid (Aib) into peptides enhances helical structure and binding affinity. This strategy creates effective helical peptide mimics with improved stability against protease cleavage, offering new therapeutic potential.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Structural Biology
Background:
- Protein-protein interactions are crucial in biological processes and disease.
- Helical peptides can disrupt these interactions, presenting therapeutic opportunities.
- Developing stable and effective helical peptide mimics is a significant challenge.
Purpose of the Study:
- To investigate alpha-amino isobutyric acid (Aib) as a sole helix promoter in designed peptides.
- To develop a general strategy for creating helical peptide mimics.
- To target the hdm2-p53 interaction, critical in cancer development.
Main Methods:
- Designed peptides by replacing non-interacting residues with Aib.
- Utilized nuclear magnetic resonance (NMR) and circular dichroism (CD) to assess helical structure.
- Evaluated the binding affinity of designed peptides with hdm2.
- Measured trypsin cleavage rates to determine protease stability.
Main Results:
- Aib incorporation significantly increased helical structure, especially in the C-terminal region.
- Enhanced binding affinity to hdm2 was observed.
- Trypsin cleavage rate was retarded by several orders of magnitude.
Conclusions:
- Aib is a feasible strategy for creating peptide helical mimics.
- These mimics exhibit enhanced receptor binding and reduced protease susceptibility.
- This approach holds promise for developing novel therapeutics targeting protein-protein interactions.